Scientists Propose Repurposing Glaucoma Drugs to Combat Aggressive Cancers
Researchers at The Institute for Cancer Research have discovered that drugs currently used to treat glaucoma could potentially be repurposed to combat aggressive cancers such as breast cancer, melanoma, and acute myeloid leukemia. The study identified a common molecular target, ROCK, which these cancers rely on to spread and become aggressive. By inhibiting this molecule, the drugs could potentially be used to treat these cancers. The research suggests that these existing drugs, already approved for glaucoma, could be fast-tracked into clinical trials for cancer treatment, potentially reaching patients more quickly. The study also identified specific markers that could help determine which patients might benefit from this treatment. 
